BRUKER CORPORATION Cash and Restricted Cash
BRUKER CORPORATION (BRKR) had Cash and Restricted Cash of $189.10 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $189.10M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $137.60M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $303.10M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $297.30M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $189.10M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $137.60M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $303.10M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $297.30M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $96.20M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $187.70M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $186.70M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $151.70M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $173.20M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $343.30M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $491.60M 10-K · filed 2026-02-27 |
| 2023-09-30 | $366.90M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $578.20M 10-Q · filed 2024-08-09 |
| 2023-03-31 | $601.40M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $648.70M 10-K · filed 2026-02-27 |
| 2022-09-30 | $629.30M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $726.30M 10-Q · filed 2023-08-09 |
| 2022-03-31 | $819.60M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $1.07B 10-K · filed 2025-03-03 |
| 2021-09-30 | $576.50M 10-Q · filed 2022-11-04 |
| 2021-06-30 | $611.70M 10-Q · filed 2022-08-05 |
| 2021-03-31 | $700.40M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $685.50M 10-K · filed 2024-02-29 |
| 2020-09-30 | $570.60M 10-Q · filed 2021-11-05 |
| 2020-06-30 | $750.40M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $798.90M 10-Q · filed 2021-05-10 |
| 2019-12-31 | $681.90M 10-K · filed 2023-03-01 |
| 2019-09-30 | $300.00M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $286.50M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $302.60M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $326.30M 10-K · filed 2022-02-28 |
| 2018-09-30 | $274.80M 10-Q · filed 2019-11-04 |
| 2018-06-30 | $262.50M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $287.80M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $328.90M 10-K · filed 2021-03-01 |
| 2017-09-30 | $267.80M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $221.40M 10-Q · filed 2018-08-09 |
| 2017-03-31 | $280.70M 10-Q · filed 2018-05-10 |
| 2016-12-31 | $345.90M 10-K · filed 2020-03-27 |
| 2015-12-31 | $271.20M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |